← Back to Patent Explorer
US4684657A Expired / Lapsed US ⏱️ 0.0 years remaining

Benzenesulphonamide derivatives

Assignee: John Wyeth and Brother Ltd
•
Filing: 1985-09-30
•
Granted: 1987-08-04
•
Expires: 2005-09-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds having the formula <IMAGE> (III) wherein X1 and X2 are independently hydrogen, halogen, trifluoromethyl, lower alkyl or lower alkoxy; X3 is halogen or trifluoromethyl; one of A and E is CH and the other is CH or N and their pharmaceutically acceptable acid addition salts are useful as pharmaceuticals, in particular as anti-hypertensive agents. Novel 1-[4-(amino or nitro)benzenesulphonyl]-4-benzoylpiperazines are also disclosed as intermediate compounds.

Inventors

  • 👤 John T. A. Boyle

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 08:35
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/16; C07D215/38; C07D215/42; C07D215/44; C07D237/00; C07D237/26; C07D237/28; C07D239/00; C07D239/70; C07D239/72; C07D239/86; C07D239/94

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 63 words
A compound selected from those having the formula ##STR18## and their pharmaceutically acceptable acid addition salts, wherein X 1 and X 2 are independently selected from hydrogen, halogen, trifluoromethyl, lower alkyl and lower alkoxy; X 3 is selected from halogen and trifluoromethyl; one of A and E is CH and the other one of A and E is selected from Ch and N.
Claim 2
Dependent Claim 63 words
A compound selected from those having the formula ##STR18## and their pharmaceutically acceptable acid addition salts, wherein X 1 and X 2 are independently selected from hydrogen, halogen, trifluoromethyl, lower alkyl and lower alkoxy; X 3 is selected from halogen and trifluoromethyl; one of A and E is CH and the other one of A and E is selected from Ch and N.
Claim 3
Dependent Claim 14 words
A compound as claimed in claim 1, wherein X 3 is at the 7-position.
Claim 4
Dependent Claim 12 words
A compound as claimed in claim 1, wherein X 3 is trifluoromethyl.
Claim 5
Dependent Claim 14 words
A compound as claimed in claim 1, wherein both A and E are CH.
Claim 6
Dependent Claim 33 words
A compound as claimed in claim 1, wherein one of X 1 and X 2 is hydrogen and the other one of X 1 and X 2 is selected from halogen and trifluoromethyl.
Claim 7
Dependent Claim 20 words
A compound as claimed in claim 1, wherein the compound having formula III is 1-[4-fluorobenzoyl]-4-[4-(7-trifluoromethyl-4-quinolinylamino)benzenesulphonyl]piperazine and its pharmaceutically acceptable salts.
Claim 8
Dependent Claim 15 words
A compound as claimed in claim 1, wherein the compound having formula III is 1-[4-(7-chloro-4-quinolinylamino)benzenesulphonyl]-4-(4-fluorobenzoyl)piperazine.
Claim 9
Dependent Claim 25 words
A pharmaceutical composition for anti-hypertensive use comprising an effective quantity of a compound as claimed in claim 1 in association with a pharmaceutically acceptable carrier.

References Cited (Backward Citations)

US3324129A Cited
US3935229A Cited
US3992382A Cited
US4025629A Cited
US4159331A Cited
US4167567A Cited
GB2021568A Cited
GB2021567A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-08-03 1991-02-02 1991-08-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-08-03 1995-02-02 1995-08-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-08-03 1999-02-02 1999-08-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag